Interleukin-17: Could it be a key player in COVID-19 infection severity?
Last updated: 25 Dec 2024
10.21608/mid.2022.166373.1390
Interleukin-17, COVID-19, Cytokines, disease severity, ICU
fatma el zahraa
fathy
Y.
Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University
drfatmayoussef@med.asu.edu.eg
cairo
0000000267877734
Nadia
Elsheshtawy
M.
Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University
nadiamohamed@med.asu.edu.eg
0000-0001-8337-526X
Mayada
Moneer
Department of internal medicine, Faculty of Medicine, Ain Shams University
mayada_moneer@med.asu.edu.eg
0000-0002-6700-9662
Amr
hosny
Department of Anaesthesia and Intensive care , Faculty of Medicine, Ain Shams University
Marwa
Abd Elgawad
Abd Elazeem
Geriatrics medicine and gerontology department , Faculty of Medicine, Ain Shams University
Amira
Abdelhamid
E.
Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University
amira.esmail2016@yahoo.com
4
1
39092
2023-02-01
2022-10-01
2023-02-01
36
43
2682-4132
2682-4140
https://mid.journals.ekb.eg/article_267362.html
https://mid.journals.ekb.eg/service?article_code=267362
7
Original Article
1,157
Journal
Microbes and Infectious Diseases
https://mid.journals.ekb.eg/
Interleukin-17: Could it be a key player in COVID-19 infection severity?
Details
Type
Article
Created At
25 Dec 2024